M&A Deal Summary |
|
|---|---|
| Date | 2024-06-25 |
| Target | BioMatrix Specialty Pharmacy |
| Sector | Life Science |
| Buyer(s) | Frazier Healthcare Partners |
| Sellers(s) |
ACON Investments
Triton Pacific Capital Partners |
| Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Growth Capital Firm |
|---|---|
| Founded | 1991 |
| PE ASSETS | 3.4B USD |
| Size | Large |
| Type | Sector Focused |
Frazier Healthcare Partners is a private equity and venture capital firm specializing in Growth buyout investment specifically targets businesses that deal Healthcare, Life Sciences, Pharmaceutical services, medical products, and related sectors. Frazier Healthcare Partners was formed in 1991 and is based in Seattle, Washington with an additional office in Palo Alto, California; Boston, Massachusetts; and Menlo Park, California.
| DEAL STATS | # |
|---|---|
| Overall | 47 of 47 |
| Sector (Life Science) | 17 of 17 |
| Type (Secondary Buyout) | 9 of 9 |
| State (Florida) | 1 of 1 |
| Country (United States) | 46 of 46 |
| Year (2024) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-12 |
Alcresta Therapeutics
Newton, Massachusetts, United States Alcresta Therapeutics is a specialty pharmaceutical company focusing on discovering and developing a new generation of enzyme-based products that improve digestion and absorption of important nutrients. The company's lead program is a point-of-care, enzyme-based product that improves the bioavailability of long-chain fatty acids (such as DHA, EPA, and AA) for patients with impaired pancreatic output. Compromised pancreatic function is a complication of many diseases such as cystic fibrosis, chronic pancreatitis, and cancer as well as developmental immaturity, and Alcresta's products are aimed at meeting the nutritional needs of these patients. Alcresta Therapeutics was formed in 2011 and is based in Newton, Massachusetts. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 6.9B USD |
| Size | Mega |
| Type | Sector Agnostic |
ACON Investments is an international private equity firm that targets investments in the US, Europe, and Latin America. ACON's investment strategy covers 'opportunities at times of change - responding at points of inflection where value creation is possible'. Examples include businesses that serve the rapidly growing US Hispanic population, energy and energy service needs, businesses in need of operational help, and opportunities in Latin America resulting from economic deregulation and political liberalization. ACON's looks for companies where it can commit $20 to $150 million of equity capital. Target sectors include consumer products and services, distribution, business services and industrial manufacturing. ACON Investments was formed in 1996 and has offices in Washington DC; Houston, Texas; Los Angeles, California; and Madrid, Spain.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 28 |
| Sector (Life Science) | 2 of 2 |
| Type (Secondary Buyout) | 2 of 3 |
| State (Florida) | 2 of 2 |
| Country (United States) | 18 of 18 |
| Year (2024) | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-01-18 |
Vitalis
Bogota, Colombia Vitalis is a manufacturer and wholesaler of generic injectable pharmaceuticals with production facilities in Colombia and Mexico. Vitalis is based in Bogota, Colombia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-07-17 |
Contenur
Getafe, Spain Contenur engages in the design, engineering and marketing of containers to the waste collection industry. The company provides all kinds of maintenance services to urban furnishing, ranging from container recycling to playground maintenance. Contenur was founded in 1985 and is based in Getafe (Madrid) and with international presence in Latam (Brazil, Colombia and Peru), Asia (Singapore) and Middle East, the company also has commercial teams and branches in the United Kingdom, France, Germany, Italy, Portugal, the Czech Republic, Poland and Morocco, as well as two manufacturing plants in Spain and Poland. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1996 |
| Size | Small |
| Type | Sector Agnostic |
Triton Pacific Capital Partners is a private equity firm focused on investing in US based small to mid-size growth companies. Triton looks to invest $5 to $15 million in companies generating $2 to $10 million of EBITDA. Sectors of interest include healthcare services, software, IT, business services, consumer products, light manufacturing, logistics, and value-added distribution. Prospective transaction situations include recapitalizations, management buyouts, growth capital financings, divestitures, and shareholder liquidity needs. Triton Pacific Capital Partners was formed in 1996 based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector (Life Science) | 2 of 2 |
| Type (Secondary Buyout) | 3 of 3 |
| State (Florida) | 1 of 1 |
| Country (United States) | 8 of 8 |
| Year (2024) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-10 |
Integrated Pain Associates
Killeen, Texas, United States Integrated Pain Associates is a medical services platform specializing in the treatment of musculoskeletal pain. Integrated Pain Associates help patients suffering from chronic pain improve their quality of life through cutting-edge treatments and surgical procedures. Integrated Pain Associates is based in Killeen, Texas. |
Buy | - |
